All Stories

  1. Investigating the effects of probiotics during the menopause transition: A systematic review & meta-analysis
  2. Associations of age at menopause, bilateral oophorectomy, hysterectomy and hormone replacement therapy with glycaemia and risk of dementia: a study based on the population-based UK Biobank cohort
  3. Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population
  4. The role of menopausal symptoms on future health and longevity: A systematic scoping review of longitudinal evidence
  5. Dissecting the contribution of human chromosome 21 syntenic regions to recognition memory processes in adult and aged mouse models of Down syndrome
  6. Biological Sex Disparities in Alzheimer’s Disease
  7. Evaluating the Effects of Probiotics on Menopause-specific Health Outcomes: A Systematic Review & Meta-analysis
  8. Upregulation of endocytic protein expression in the Alzheimer’s disease male human brain
  9. APOE-ε4-related differences in left thalamic microstructure in cognitively healthy adults
  10. Characterisation of negative allosteric modulators of the calcium-sensing receptor, CaSR, for repurposing as a treatment for asthma
  11. Genetic risk of dementia modifies obesity effects on white matter myelin in cognitively healthy adults
  12. Correction to: ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
  13. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
  14. Genetic risk of dementia modifies the impact of obesity on limbic white matter and spatial navigation behavior in cognitively healthy adults
  15. Sex-specific effects of central adiposity and inflammatory markers on limbic microstructure
  16. Selective reduction of APP-BACE1 activity improves memory via NMDA-NR2B receptor-mediated mechanisms in aged PDAPP mice
  17. Adipokines contribute to central-obesity related reductions in myelin-sensitive MRI indices in the fornix
  18. A rapidly acquired foraging-based working memory task, sensitive to hippocampal lesions, reveals age-dependent and age-independent behavioural changes in a mouse model of amyloid pathology
  19. Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology
  20. Death Receptor 3 regulates distinct pathological attributes of acute versus chronic murine allergic lung inflammation
  21. Proteins involved in endocytosis are upregulated by ageing in the normal human brain: implications for the development of Alzheimer’s disease.
  22. Route of Administration Affects Corticosteroid Sensitivity of a Combined Ovalbumin and Lipopolysaccharide Model of Asthma Exacerbation in Guinea Pigs
  23. Effects of nebulised magnesium sulphate on inflammation and function of the guinea-pig airway
  24. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer’s disease
  25. Calcium-sensing receptor antagonists abrogate airway hyperresponsiveness and inflammation in allergic asthma
  26. Pulmonary edema measured by MRI correlates with late-phase response to allergen challenge
  27. LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthma
  28. Adjustment of sensitisation and challenge protocols restores functional and inflammatory responses to ovalbumin in guinea-pigs
  29. Abstracts from the 12th meeting of the International Society for Neural Transplantation and Restoration
  30. Inhibition of amyloid-β production by anti-amyloid precursor protein antibodies in primary mouse cortical neurones
  31. Human parainfluenza type 3 virus impairs the efficacy of glucocorticoids to limit allergy-induced pulmonary inflammation in guinea-pigs
  32. Functional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetamines
  33. A comparison of antiasthma drugs between acute and chronic ovalbumin-challenged guinea-pig models of asthma
  34. Bronchoprotection in conscious guinea pigs by budesonide and the NO‐donating analogue, TPI 1020, alone and combined with tiotropium or formoterol
  35. Third (2011) UK Purine Club annual symposium report
  36. Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer’s disease-like amyloid pathology
  37. Actions of Artemisia vulgaris extracts and isolated sesquiterpene lactones against receptors mediating contraction of guinea pig ileum and trachea
  38. Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
  39. Outcome-specific satiety reveals a deficit in context-outcome, but not stimulus- or action-outcome, associations in aged Tg2576 mice.
  40. Anti-amyloid precursor protein immunoglobulins inhibit amyloid-β production by steric hindrance
  41. Bradykinin-Induced Lung Inflammation and Bronchoconstriction: Role in Parainfluenze-3 Virus-Induced Inflammation and Airway Hyperreactivity
  42. Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine
  43. TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol in conscious guinea-pigs
  44. Increased muscarinic receptor activity of airway smooth muscle isolated from a mouse model of allergic asthma
  45. Atypical P2X7 receptor pharmacology in two human osteoblast-like cell lines
  46. Dietary trace amine-dependent vasoconstriction in porcine coronary artery
  47. Effects of dietary amines on the gut and its vasculature
  48. Activation of β-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction
  49. Establishing the phenotype in novel acute and chronic murine models of allergic asthma
  50. Protective role of β2- and β3-adrenoceptors at reperfusion in isolated rat heart
  51. Radioligand binding and functional responses of ligands for human recombinant adenosine A3 receptors
  52. P2X7 Receptors Are Redistributed on Human Monocytes after Pore Formation in Response to Prolonged Agonist Exposure
  53. Distribution of P2X1 and P2X3 Receptors in the Rat and Human Urinary Bladder
  54. Apparent species differences in the kinetic properties of P2X7receptors
  55. Distribution of P2X3 receptors in the rat trigeminal ganglion after inferior alveolar nerve injury
  56. Molecular cloning and functional characterization of a rat somatostatin sst2(b)receptor splice variant
  57. Evidence for P2X3 receptors in the developing rat brain
  58. Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa
  59. POSTER COMMUNICATIONS
  60. A quantitative autoradiographical study on the distribution of somatostatin sst2 receptors in the rat central nervous system using [125I]-BIM-23027
  61. POSTER COMMUNICATIONS
  62. Autoradiographic distribution of [3H]l-NG-Nitro-arginine binding in rat brain
  63. POSTER COMMUNICATIONS
  64. Characterisation of the non-5-HT3 high-affinity ‘R’ binding site for (R)-zacopride in brain and other tissues
  65. (?)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain
  66. 5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals
  67. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system
  68. Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release
  69. Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI
  70. Chronic 5-HT2 receptor antagonist treatment alters 5-HT1A autoregulatory control of 5-HT release in rat brain in vivo
  71. Autoradiographic measurement of 5-HT2 and 5-HT1C receptors an rat brain after chronic treatment with ritanserin and DOM
  72. Cortical 5-HT release in vivo after repeated treatment with a 5-HT2 agonist and a thyrotrophin releasing hormone analogue
  73. MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptors
  74. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor